Mark Perla

Director, Tax Planning at Novartis - Basel, Basel-City, CH

Mark Perla's Colleagues at Novartis
Javier Gesualdo

Medical Strategy Director

Contact Javier Gesualdo

Emily Krimbel

Associate Director, Portfolio Communications, CRM

Contact Emily Krimbel

Asif Islam

Non Executive Director

Contact Asif Islam

Nancy Viscio

Director, Regulatory CMC, Global Drug Development

Contact Nancy Viscio

Iris Wang

Senior Director, Global Precision Medicine

Contact Iris Wang

Albert Hsu

director, market access pipeline and launch excellence

Contact Albert Hsu

Christina Bender

director, global oncology, diagnostic commercial strategy

Contact Christina Bender

View All Mark Perla's Colleagues
Mark Perla's Contact Details
HQ
+41 61 324 11 11
Location
Company
Novartis
Mark Perla's Company Details
Novartis logo, Novartis contact details

Novartis

Basel, Basel-City, CH • 79173 Employees
Major Drugs

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Pharmaceutical Drugs Innovative Medicine Healthcare Solution Biotechnology Medical Research Clinical Trials Pharmaceutical Manufacturing Drug Development And Manufacturing Health Technology
Details about Novartis
Frequently Asked Questions about Mark Perla
Mark Perla currently works for Novartis.
Mark Perla's role at Novartis is Director, Tax Planning.
Mark Perla's email address is ***@novartis.com. To view Mark Perla's full email address, please signup to ConnectPlex.
Mark Perla works in the Major Drugs industry.
Mark Perla's colleagues at Novartis are Javier Gesualdo, Emily Krimbel, Asif Islam, Nancy Viscio, Iris Wang, Albert Hsu, Christina Bender and others.
Mark Perla's phone number is +41 61 324 11 11
See more information about Mark Perla